Evidence-based Prevention of Surgical Site Infection

Surg Clin North Am. 2021 Dec;101(6):951-966. doi: 10.1016/j.suc.2021.05.027.

Abstract

Surgical site infection (SSI) remains an important complication of surgery. SSI is estimated to affect 2% to 5% of all surgical patients. Local and national efforts have resulted in significant improvements in the incidence of SSI. Familiarity with evidence surrounding high-quality SSI-reduction strategies is desirable. There exists strong evidence for mechanical and oral antibiotic bowel preparation in colorectal surgery, smoking cessation before elective surgery, prophylactic antibiotics, chlorhexidine-based skin antisepsis, and maintenance of normothermia throughout the perioperative period to reduce SSI. Use of other practices should be determined by the operating surgeon and/or local hospital policy.

Keywords: Enhanced recovery after surgery; SSI; SSI bundles; Surgical site infection.

Publication types

  • Review

MeSH terms

  • Evidence-Based Medicine
  • Humans
  • Surgical Wound Infection / etiology
  • Surgical Wound Infection / prevention & control*